With its acceptance by the NMPA, NVK002 is now under regulatory review across three major global markets: the United States, the European Union, and China. This milestone reinforces Vyluma’s vision of ...

He shared the reasons behind his approval. "Well, I think that, in the end, he respects the process. I think a lot of the ...

The partners expect the FDA to complete its review process in the fourth quarter ... that impacts nearly 30 million people in China. The drug was approved by China’s National Medical Products ...

India's pharmaceutical industry holds immense promise, but experts and stakeholders assert that to unlock its full potential, ...

HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the supplemental New Drug Application for ORPATHYS ® (savolitinib) has been granted approval by the ...

China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication associated with bone marrow transplant, as well as a novel HIV drug that only ...

Kelun-Biotech has become the second drugmaker to bring a TROP2-directed antibody-drug conjugate to regulatory approval, getting a green light in China for sacituzumab tirumotecan (sac-TMT).

“The approval further adds to Biocon’s portfolio of complex drug products and will be commercialised in the region expeditiously,” the company stated. In the second quarter of 2024, Biocon ...

Eli Lilly has chalked up another regulatory approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the ... 2024 forecasts for the drug, but reined them in again ...

China Resources Pharmaceutical ... into the human body. The drug, developed by US pharmaceutical giant Pfizer for certain types of advanced breast cancer, was approved for sale in 2015.

Patented genetics from Charlotte’s Web were used in the process. There are very rare instances when cannabis-based drug candidates have achieved FDA approval, with only one containing cannabis ...

The Phase I study, currently underway at Beijing Cancer Hospital in China, aims to evaluate ... AI technologies to propel the entire drug discovery process—from drug target discovery to efficacy ...